Acceleron Pharma Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Acceleron Pharma Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary
Marketline's Acceleron Pharma Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Acceleron Pharma Inc. since January2007.
Synopsis
Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Key Highlights
This report includes Acceleron Pharma Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Acceleron Pharma Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Scope
Summary
Marketline's Acceleron Pharma Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Acceleron Pharma Inc. since January2007.
Synopsis
Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Key Highlights
This report includes Acceleron Pharma Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Acceleron Pharma Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Scope
- Provides intelligence on Acceleron Pharma Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Acceleron Pharma Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Acceleron Pharma Inc.'s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Acceleron Pharma Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.
COMPANY OVERVIEW AND KEY FACTS
TABLE OF CONTENTS
TABLE OF CONTENTS
LIST OF TABLES
LIST OF FIGURES
PARTNERSHIP
Partnership - Deal reports
CAPITAL RAISING
Capital Raising - Overview
Capital Raising - Deal reports
APPENDIX
Contact Us
About MarketLine Financial Deals Database
Deal Definition and Methodology
About MarketLine
LIST OF TABLES
Table 1: Mitsubishi Tanabe Pharma Corporation partnership volume and value trend (2014-YTD2018)
Table 2: Mitsubishi Tanabe Pharma Corporation partnership trend by key deal type (2014-YTD2018)
LIST OF FIGURES
Figure 1: Novo Nordisk A/S M&A volume and value trend (2014-YTD2018)
Figure 2: Novo Nordisk A/S M&A activity by geography (2014-YTD2018)
Figure 3: Novo Nordisk A/S corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Novo Nordisk A/S corporate venturing by geography (2014-YTD2018)
Figure 5: Novo Nordisk A/S partnership volume and value trend (2014-YTD2018)
Figure 6: Novo Nordisk A/S partnership trend by key deal type (2014-YTD2018)
Figure 7: Novo Nordisk A/S divestments volume and value trend (2014-YTD2018)
Figure 8: Novo Nordisk A/S divestments by geography (2014-YTD2018)
PARTNERSHIP
Partnership - Deal reports
CAPITAL RAISING
Capital Raising - Overview
Capital Raising - Deal reports
APPENDIX
Contact Us
About MarketLine Financial Deals Database
Deal Definition and Methodology
About MarketLine
LIST OF TABLES
Table 1: Mitsubishi Tanabe Pharma Corporation partnership volume and value trend (2014-YTD2018)
Table 2: Mitsubishi Tanabe Pharma Corporation partnership trend by key deal type (2014-YTD2018)
LIST OF FIGURES
Figure 1: Novo Nordisk A/S M&A volume and value trend (2014-YTD2018)
Figure 2: Novo Nordisk A/S M&A activity by geography (2014-YTD2018)
Figure 3: Novo Nordisk A/S corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Novo Nordisk A/S corporate venturing by geography (2014-YTD2018)
Figure 5: Novo Nordisk A/S partnership volume and value trend (2014-YTD2018)
Figure 6: Novo Nordisk A/S partnership trend by key deal type (2014-YTD2018)
Figure 7: Novo Nordisk A/S divestments volume and value trend (2014-YTD2018)
Figure 8: Novo Nordisk A/S divestments by geography (2014-YTD2018)
